Complement activating and opsonic capacity of monoclonal antibodies raised againstEscherichia coli O111 and its rough mutant J5
- 1 April 1986
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 5 (2) , 141-147
- https://doi.org/10.1007/bf02013969
Abstract
Six monoclonal antibodies raised againstEscherichia coli O111 and against its rough mutant J5 (chemotype Rc) were studied. One IgG2A, one IgM anti-J5, and one IgG2A anti-O111 monoclonal antibody did not bind to lipopolysaccharides of the homologous strain, but cross-reacted with heterologous gram-negative rods in an enzyme-linked immunosorbent assay. These three monoclonal antibodies activated complement when incubated with homologous or heterologous strains, but were opsonic neither in the presence nor in the absence of complement. The other three monoclonal antibodies were directed against lipopolysaccharide of the homologous strain, but showed no cross-reactivity. The IgG3 and one IgM anti-J5 monoclonal antibodies activated complement and were opsonic only in the presence of complement. The IgM anti-O111 monoclonal antibody activated complement and was opsonic both in the presence and absence of complement. Thus, the outcome of the interaction between bacteria, antibodies, and complement is influenced primarily by whether antibodies are directed against lipopolysaccharides or against other cell wall components.This publication has 38 references indexed in Scilit:
- Immunization with Rough Mutants of Salmonella minnesota. IV. Protection by Antisera to O and Rough Antigens Against EndotoxinThe Journal of Infectious Diseases, 1983
- The Treatment of Gram-Negative Bacteremia and ShockNew England Journal of Medicine, 1982
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.Journal of Clinical Investigation, 1982
- Production of monoclonal antibodies: Strategy and tacticsJournal of Immunological Methods, 1980
- A better cell line for making hybridomas secreting specific antibodiesNature, 1978
- Neutralization of meningococcal endotoxin by antibody to core glycolipid.The Journal of Experimental Medicine, 1978
- Functional role of antibody against "core" glycolipid of Enterobacteriaceae.Journal of Clinical Investigation, 1975
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- A New Method for the Extraction of R LipopolysaccharidesEuropean Journal of Biochemistry, 1969